Showing results (1361-1370 of 1,401) with videos related to

Sort By:
Pageof 141
American Journal of Physiology. Endocrinology and Metabolism|December 26, 2025
GLOBAL LOSS OF SELENOCYSTEINE LYASE IN MICE DRIVES LIPID ACCUMULATION IN BROWN ADIPOCYTESBriana K Shimada, Ashley N Ogawa-Wong, Antonio G Soares, et al.
Journal of Virology|October 12, 2012
Correlates of protective cellular immunity revealed by analysis of population-level immune escape pathways in HIV-1Jonathan M Carlson, Chanson J Brumme, Eric Martin, et al.
Plos Computational Biology|April 13, 2012
RNA-Seq mapping and detection of gene fusions with a suffix array algorithmOnur Sakarya, Heinz Breu, Milan Radovich, et al.
Mucosal Immunology|January 26, 2024
Comparison of Omicron breakthrough infection versus monovalent SARS-CoV-2 intramuscular booster reveals differences in mucosal and systemic humoral immunitySabryna Nantel, Salma Sheikh-Mohamed, Gary Y C Chao, et al.
The Journal of Infectious Diseases|December 10, 2021
Reduced Magnitude and Durability of Humoral Immune Responses to COVID-19 mRNA Vaccines Among Older AdultsMark A Brockman, Francis Mwimanzi, Hope R Lapointe, et al.
Plos Pathogens|September 5, 2018
HLA-C downregulation by HIV-1 adapts to host HLA genotypeNathaniel D Bachtel, Gisele Umviligihozo, Suzanne Pickering, et al.
Cell Reports Methods|March 20, 2023
Blood RNA alternative splicing events as diagnostic biomarkers for infectious diseaseZijun Zhang, Natalie Sauerwald, Antonio Cappuccio, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2026
Beyond Rurality: Individual Socioeconomic Status and Chronic Disease PrevalenceShivani Sabarish, Chung-Il Wi, Madison Beenken, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 6, 2023
CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor RegressionJordan L Kohlmeyer, Joshua J Lingo, Courtney A Kaemmer, et al.
Frontiers in Immunology|September 23, 2022
Serial infection with SARS-CoV-2 Omicron BA.1 and BA.2 following three-dose COVID-19 vaccinationHope R Lapointe, Francis Mwimanzi, Peter K Cheung, et al.
Pageof 141